NicotinamidePromotes MSC differentiation; anti-inflammatory agent CAS# 98-92-0 |
2D Structure
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
Cas No. | 98-92-0 | SDF | Download SDF |
PubChem ID | 936 | Appearance | White powder |
Formula | C6H6N2O | M.Wt | 122.13 |
Type of Compound | Alkaloids | Storage | Desiccate at -20°C |
Synonyms | Niacinamide; Nicotinic acid amide; Vitamin B3 | ||
Solubility | DMSO : ≥ 100 mg/mL (818.87 mM) H2O : ≥ 50 mg/mL (409.43 mM) *"≥" means soluble, but saturation unknown. | ||
Chemical Name | pyridine-3-carboxamide | ||
SMILES | C1=CC(=CN=C1)C(=O)N | ||
Standard InChIKey | DFPAKSUCGFBDDF-UHFFFAOYSA-N | ||
Standard InChI | InChI=1S/C6H6N2O/c7-6(9)5-2-1-3-8-4-5/h1-4H,(H2,7,9) | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | Nicotinamide is a form of vitamin B3 that plays essential roles in cell physiology through facilitating NAD+ redox homeostasis and providing NAD+ as a substrate to a class of enzymes that catalyze non-redox reactions. Nicotinamide is an inhibitor of SIRT1, it has insulinotropic action, it can induce differentiation and maturation of human fetal pancreatic islet cells. Nicotinamide may represent a safe treatment for Alzheimer's disease and other tauopathies, and that phosphorylation of tau at Thr231 may regulate tau stability. |
Targets | NADPH-oxidase | Sirtuin | p53 | DNA/RNA Synthesis | SIRT1 | HDAC |
In vitro | Nicotinamide restores cognition in Alzheimer's disease transgenic mice via a mechanism involving sirtuin inhibition and selective reduction of Thr231-phosphotau.[Pubmed: 18987186 ]J Neurosci. 2008 Nov 5;28(45):11500-10.Memory loss is the signature feature of Alzheimer's disease, and therapies that prevent or delay its onset are urgently needed. Effective preventive strategies likely offer the greatest and most widespread benefits. Histone deacetylase (HDAC) inhibitors increase histone acetylation and enhance memory and synaptic plasticity. Nicotinamide and PNC1 govern lifespan extension by calorie restriction in Saccharomyces cerevisiae.[Pubmed: 12736687]Nature. 2003 May 8;423(6936):181-5.Calorie restriction extends lifespan in a broad range of organisms, from yeasts to mammals. Numerous hypotheses have been proposed to explain this phenomenon, including decreased oxidative damage and altered energy metabolism. Nicotinamide is a potent inducer of endocrine differentiation in cultured human fetal pancreatic cells.[Pubmed: 8104197]J Clin Invest. 1993 Sep;92(3):1459-66.The effects of Nicotinamide (NIC) on human fetal and adult endocrine pancreatic cells were studied in tissue culture. |
Kinase Assay | Nicotinamide mononucleotide activation of new DNA-dependent polyadenylic acid synthesizing nuclear enzyme.[Reference: WebLink]Biochem. Biophys. Res. Commun., 1963, 11(1): 39-43.Nicotinamide mononucleotide activation of new DNA-dependent polyadenylic acid synthesizing nuclear enzyme. |
Nicotinamide Dilution Calculator
Nicotinamide Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 8.188 mL | 40.94 mL | 81.88 mL | 163.7599 mL | 204.6999 mL |
5 mM | 1.6376 mL | 8.188 mL | 16.376 mL | 32.752 mL | 40.94 mL |
10 mM | 0.8188 mL | 4.094 mL | 8.188 mL | 16.376 mL | 20.47 mL |
50 mM | 0.1638 mL | 0.8188 mL | 1.6376 mL | 3.2752 mL | 4.094 mL |
100 mM | 0.0819 mL | 0.4094 mL | 0.8188 mL | 1.6376 mL | 2.047 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
Nicotinamide is a water-soluble vitamin, an active component of coenzymes NAD and NADP, and acts as poly (ADP-ribose) polymerase (PARP) inhibitor.
In Vitro:Pretreatment with the poly (ADP-ribose) polymerase (PARP) inhibitor nicotinamide is able to prevent HCN2 cell death. When nicotinamide is added prior to t-BuOOH, it is able to prevent neuronal cell death and inhibit apoptosis. Nicotinamide-pretreated neurons have higher expression levels of inhibitors of apoptosis (IAP) genes[1]. Nicotinamide inhibits vasoconstriction by ET. Nicotinamide also alleviates oxidative stress, which exacerbates PE and FGR[3].
In Vivo:Normal and streptozotocin-nicotinamide induced adult male diabetic rats receive quercetin (10, 25 and 50 mg/kg/bw) orally, and cause significant decrease in FBG and cardiac injury marker levels with increased in insulin levels[2]. Nicotinamide improves maternal hypertension, proteinuria, and glomerular endotheliosis in RUPP mice. Moreover, nicotinamide prolongs pregnancies, and improves survival and growth of the embryos in RUPP PE mice[3].
References:
[1]. Bhansali SG, et al. Nicotinamide prevents apoptosis in human cortical neuronal cells. Toxicol Mech Methods. 2006;16(4):173-80.
[2]. Roslan J, et al. Quercetin ameliorates oxidative stress, inflammation and apoptosis in the heart of streptozotocin-nicotinamide-induced adult male diabetic rats. Biomed Pharmacother. 2016 Dec 24;86:570-582
[3]. Fushima T, et al. Nicotinamide ameliorates a preeclampsia-like condition in mice with reduced uterine perfusion pressure. Am J Physiol Renal Physiol. 2016 Dec 7:ajprenal.00501.2016
[4]. Suzuki E, et al. Protective effect of nicotinamide against poly(ADP-ribose) polymerase-1-mediated astrocyte death depends on its transporter-mediated uptake. Life Sci. 2010 Apr 24;86(17-18):676-82.
- Acetophenone
Catalog No.:BCN8300
CAS No.:98-86-2
- H-Pyr-OH
Catalog No.:BCC3328
CAS No.:98-79-3
- Terpineol
Catalog No.:BCN3595
CAS No.:98-55-5
- 4-Aminophenylarsonic acid
Catalog No.:BCC8688
CAS No.:98-50-0
- Benzenesulfonic acid
Catalog No.:BCC8846
CAS No.:98-11-3
- Methyl (E)-3'-hydroxy-4'-methoxycinnamate
Catalog No.:BCN1294
CAS No.:97966-29-5
- Leachianone A
Catalog No.:BCN4530
CAS No.:97938-31-3
- Sophoraflavanone G
Catalog No.:BCN2987
CAS No.:97938-30-2
- Methyl 3-carbazolecarboxylate
Catalog No.:BCN4529
CAS No.:97931-41-4
- 3,4'-Dihydroxy-3,5',7-trimethoxyflavan
Catalog No.:BCN4528
CAS No.:97914-19-7
- Estradiol valerate
Catalog No.:BCC4482
CAS No.:979-32-8
- Norfloxacin lactate
Catalog No.:BCC9104
CAS No.:97867-34-0
- Pyrazinamide
Catalog No.:BCC4932
CAS No.:98-96-4
- Brompheniramine hydrogen maleate
Catalog No.:BCC4515
CAS No.:980-71-2
- Lomefloxacin HCl
Catalog No.:BCC4673
CAS No.:98079-52-8
- Lupinalbin A
Catalog No.:BCN8191
CAS No.:98094-87-2
- Ailanthone
Catalog No.:BCN4531
CAS No.:981-15-7
- Difloxacin HCl
Catalog No.:BCC3764
CAS No.:98106-17-3
- 5,2',6'-Trihydroxy-6,7,8-trimethoxyflavone
Catalog No.:BCN1293
CAS No.:98187-98-5
- Eltoprazine hydrochloride
Catalog No.:BCC5422
CAS No.:98224-03-4
- Eltoprazine
Catalog No.:BCC5421
CAS No.:98206-09-8
- Hupehenine
Catalog No.:BCN2617
CAS No.:98243-57-3
- Isotanshinone II
Catalog No.:BCN3002
CAS No.:98249-39-9
- Boc-D-2-Pal-OH
Catalog No.:BCC2654
CAS No.:98266-32-1
Nicotinamide and PNC1 govern lifespan extension by calorie restriction in Saccharomyces cerevisiae.[Pubmed:12736687]
Nature. 2003 May 8;423(6936):181-5.
Calorie restriction extends lifespan in a broad range of organisms, from yeasts to mammals. Numerous hypotheses have been proposed to explain this phenomenon, including decreased oxidative damage and altered energy metabolism. In Saccharomyces cerevisiae, lifespan extension by calorie restriction requires the NAD+-dependent histone deacetylase, Sir2 (ref. 1). We have recently shown that Sir2 and its closest human homologue SIRT1, a p53 deacetylase, are strongly inhibited by the vitamin B3 precursor Nicotinamide. Here we show that increased expression of PNC1 (pyrazinamidase/nicotinamidase 1), which encodes an enzyme that deaminates Nicotinamide, is both necessary and sufficient for lifespan extension by calorie restriction and low-intensity stress. We also identify PNC1 as a longevity gene that is responsive to all stimuli that extend lifespan. We provide evidence that Nicotinamide depletion is sufficient to activate Sir2 and that this is the mechanism by which PNC1 regulates longevity. We conclude that yeast lifespan extension by calorie restriction is the consequence of an active cellular response to a low-intensity stress and speculate that Nicotinamide might regulate critical cellular processes in higher organisms.
Nicotinamide is a potent inducer of endocrine differentiation in cultured human fetal pancreatic cells.[Pubmed:8104197]
J Clin Invest. 1993 Sep;92(3):1459-66.
The effects of Nicotinamide (NIC) on human fetal and adult endocrine pancreatic cells were studied in tissue culture. Treatment of the fetal cells with 10 mM NIC resulted in a twofold increase in DNA content and a threefold increase in insulin content. This was associated with the development of beta cell outgrowths from undifferentiated epithelial cell clusters and an increase in the expression of the insulin, glucagon, and somatostatin genes. DNA synthesis was stimulated only in the undifferentiated cells. Half-maximal doses for the insulinotropic and mitogenic effects of NIC were 5-10 and 1-2 mM, respectively. Islet-like cell clusters cultured with NIC responded to glucose stimulation with a biphasic increase in insulin release (fourfold peak), whereas control cells were unresponsive to glucose. Both control and NIC-treated cells developed into functional islet tissue after transplantation into athymic nude mice. As compared with adult islets, the insulinotropic action of NIC could only be demonstrated in the fetal cells. Our results indicate that NIC induces differentiation and maturation of human fetal pancreatic islet cells. This model should be useful for the study of molecular mechanisms involved in beta cell development.
A modified method of insulin producing cells' generation from bone marrow-derived mesenchymal stem cells.[Pubmed:25405207]
J Diabetes Res. 2014;2014:628591.
Type 1 diabetes mellitus is a result of autoimmune destruction of pancreatic insulin producing beta-cells and so far it can be cured only by insulin injection, by pancreas transplantation, or by pancreatic islet cells' transplantation. The methods are, however, imperfect and have a lot of disadvantages. Therefore new solutions are needed. The best one would be the use of differentiated mesenchymal stem cells (MSCs). In the present study, we investigated the potential of the bone marrow-derived MSCs line for in vitro differentiation into insulin producing cells (IPSs). We applied an 18-day protocol to differentiate MSCs. Differentiating cells formed cell clusters some of which resembled pancreatic islet-like cells. Using dithizone we confirmed the presence of insulin in the cells. What is more, the expression of proinsulin C-peptide in differentiated IPCs was analyzed by flow cytometry. For the first time, we investigated the influence of growth factors' concentration on IPCs differentiation efficiency. We have found that an increase in the concentration of growth factors up to 60 ng/mL of beta-FGF/EGF and 30 ng/mL of activin A/beta-cellulin increases the percentage of IPCs. Further increase of growth factors does not show any increase of the percentage of differentiated cells. Our findings suggest that the presented protocol can be adapted for differentiation of insulin producing cells from stem cells.
Protective effect of nicotinamide against poly(ADP-ribose) polymerase-1-mediated astrocyte death depends on its transporter-mediated uptake.[Pubmed:20188745]
Life Sci. 2010 Apr 24;86(17-18):676-82.
AIM: Poly(ADP-ribose) polymerase-1 (PARP-1) is a DNA repair enzyme, and its excessive activation, following ischemia, trauma, etc., depletes cellular Nicotinamide adenine dinucleotide (NAD(+)) as a substrate and eventually leads to brain cell death. Nicotinamide, an NAD(+) precursor and a PARP-1 inhibitor, is known to prevent PARP-1-triggered cell death, but there is no available information on the mechanisms involved in its transport. Here we clarified the transport characteristics of Nicotinamide in primary cultured mouse astrocytes. MAIN METHODS: Uptake characteristics of [(14)C]Nicotinamide were assessed by a conventional method with primary cultured mouse astrocytes. Cell viability and PARP-1 activity were determined with intracellular LDH activity and immunocytochemical detection of PAR accumulation, respectively. KEY FINDINGS: PARP-1 activation was induced by treatment of astrocytes with N-methyl-N'-nitro-N-nitrosoguanidine (MNNG), an alkylating agent. MNNG-triggered astrocyte death and PAR accumulation were completely inhibited by treatment with Nicotinamide as with DPQ (3,4-dihydro-5-(4-(1-piperidinyl)butoxy)-1(2H)-isoquinolinone), a second generation PARP inhibitor. The uptake of [(14)C]Nicotinamide was time-, temperature-, concentration- and pH-dependent, and was inhibited and stimulated by co- and pre-treatment with N-methylNicotinamide, a representative substrate of an organic cation transport system, respectively. Co-treatment of astrocytes with Nicotinamide and N-methylNicotinamide resulted in a decrease in PAR accumulation and absolute prevention of cell death. SIGNIFICANCE: These findings suggest that Nicotinamide has a protective effect against PARP-1-induced astrocyte death and that its transporter-mediated uptake, which is extracellular pH-sensitive and common to N-methylNicotinamide, is critical for prevention of PARP-1-triggered cell death.
Nicotinamide rescues human embryonic stem cell-derived neuroectoderm from parthanatic cell death.[Pubmed:19544437]
Stem Cells. 2009 Aug;27(8):1772-81.
Abundant cell death is observed when human embryonic stem cells (hESCs) undergo neuralization, a critical first step for future cell-based therapies addressing neurodegeneration. Using hESC neuralization as an in vitro model of human development, we demonstrated that the developing neuroepithelium acquires increased susceptibility to spontaneous cell death. We found that poly(ADP-ribose) polymerase-1 (PARP1)/apoptosis-inducing factor (AIF)-mediated cell death (parthanatos) is a dominant mechanism responsible for cell loss during hESC neuralization. The demise of neural progenitor cells, at least in part, is due to decreased endogenous antioxidant defenses and enhanced reactive oxygen species leakage from mitochondria fuelled by nonphysiological culture conditions. Under such conditions, PARP1 overactivation triggered cell death through the mitochondrial-nuclear translocation of AIF. Blocking PARP1 activity with small hairpin RNA interference or Nicotinamide dramatically enhanced hESC neuralization, providing optimal survival of the developing neuroepithelium. Because Nicotinamide is a physiological metabolite, our results raise the possibility that neural stem/progenitor cell survival in vivo requires a metabolic niche. We argue that small natural metabolites provide a powerful physiological tool to optimize hESC differentiation compatible with the requirements of regenerative medicine.